Mckesson Corp
MCK - NEW YORK STOCK EXCHANGE, INC.
Industry: Health Care
Market Cap: 86.9 B
IPO Date: Nov 10, 1994
Country: US
Currency: USD
Shares Outstanding: 125.3 M
McKesson : Q4 2025 McKesson Corporation Earnings Conference Call Transcript
5/10/2025
08-May-2025 McKesson Corp. Q4 2025 Earnings Call CORPORATE PARTICIPANTS Jeni Dominguez Vice President Investor...
Source: Finnhub
Why McKesson Stock Bumped Modestly Higher Today
5/9/2025
The company posted double-digit-percentage improvements in its latest set of quarterly results. Storied healthcare supplies company McKesson (NYSE: MCK) was a slight outperformer on the stock exchange Friday, as investors considered its results for its fourth quarter of fiscal 2025. After market hours Thursday, McKesson divulged that it earned revenue of $90.8 billion for the period, a meaty 19% improvement over the same quarter the previous year.
Source: Yahoo
McKesson's Fiscal Q4 'More Loaded Than Normal' Amid Spin-Off News, UBS Says
5/9/2025
McKesson's (MCK) fiscal Q4 update was "more loaded than normal," UBS Securities said in a note Frida
Source: Yahoo
Health Care Down Sharply on Drug-Demand Fears -- Health Care Roundup
5/9/2025
Health-care companies fell sharply amid concerns about the outlook for the pharmaceutical business. The health-care sector has experienced significant volatility so far in 2025, as the Trump...
Source: Finnhub
McKesson (NYSE:MCK) Reports US$90 Billion Sales With 66% Q4 Net Income Rise
5/9/2025
McKesson (NYSE:MCK) recently reported a significant increase in earnings for the fourth quarter and full year, reflecting robust growth in sales and net income. This performance, alongside the launch of its Precision Care Companion initiative in April, highlights the company's strategic focus on improving healthcare outcomes. Simultaneously, McKesson's declared dividend and the strong financial results likely bolstered investor confidence, aligning with a broader market trend of 1.3% growth...
Source: Yahoo
MCK Stock Up on Q4 Earnings Beat & Potential Surgical Biz Spin-Off
5/9/2025
McKesson's fourth-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales.
Source: Yahoo
McKesson's (NYSE:MCK) investors will be pleased with their enviable 452% return over the last five years
5/9/2025
Buying shares in the best businesses can build meaningful wealth for you and your family. And we've seen some truly...
Source: Yahoo
McKesson: Spinoff Of Medical-Surgical Solutions Is A Positive, Strong Buy
5/9/2025
McKesson is a Strong Buy with growth in oncology and biopharma, 19% revenue surge, and a focus on high-growth pharma markets. Read why MCK is a Strong Buy.
Source: SeekingAlpha
McKesson : Q4 2025 McKesson Corporation Earnings Transcript
5/9/2025
08-May-2025 McKesson Corp. Q4 2025 Earnings Call CORPORATE PARTICIPANTS Jeni Dominguez Vice President Investor...
Source: Finnhub
McKesson : Fourth Quarter 2025 Transcript
5/9/2025
08-May-2025 McKesson Corp. Q4 2025 Earnings Call CORPORATE PARTICIPANTS Jeni Dominguez Vice President Investor...
Source: Finnhub
McKesson Corp (MCK) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...
5/9/2025
McKesson Corp (MCK) reports a robust 16% increase in full-year revenue, driven by strategic acquisitions and strong performance in key segments.
Source: Yahoo
Here's What Key Metrics Tell Us About McKesson (MCK) Q4 Earnings
5/8/2025
While the top- and bottom-line numbers for McKesson (MCK) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Source: Yahoo
McKesson to spin off surgical supplies unit, forecasts strong annual profit
5/8/2025
Shares of the drug distributor rose 2% in extended trading. The company said separation of the unit, which supplies surgical instruments and services, will allow it to focus on distribution of cancer drugs and other specialty medicines, which have shown higher growth and provide better margins.
Source: Yahoo
McKesson (NYSE:MCK) Misses Q1 Revenue Estimates
5/8/2025
Healthcare distributor and services company McKesson (NYSE:MCK) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 18.9% year on year to $90.82 billion. Its non-GAAP profit of $10.12 per share was 3% above analysts’ consensus estimates.
Source: Yahoo
McKesson to Spin Off Medical-Surgical Company
5/8/2025
The pharmaceutical distributor said the new company would be a differentiated medical surgical supply and solutions business.
Source: Yahoo
McKesson (MCK) Tops Q4 Earnings Estimates
5/8/2025
McKesson (MCK) delivered earnings and revenue surprises of 3.16% and 3.08%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Source: Yahoo
McKesson: Fiscal Q4 Earnings Snapshot
5/8/2025
On a per-share basis, the Irving, Texas-based company said it had profit of $10.01. Earnings, adjusted for one-time gains and costs, came to $10.12 per share. The results exceeded Wall Street expectations.
Source: Yahoo
McKesson Reports Fiscal 2025 Fourth Quarter and Full Year Results and Provides Fiscal 2026 Guidance; Announces Intent to Separate Medical-Surgical Solutions
5/8/2025
IRVING, Texas, May 08, 2025--McKesson Corporation (NYSE: MCK) has released its fiscal 2025 fourth quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
Source: Yahoo
McKesson Corporation 2025 Q4 - Results - Earnings Call Presentation
5/8/2025
The following slide deck was published by McKesson Corporation in conjunction with their 2025 Q4 earnings call.
Source: SeekingAlpha